Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Adrenal Insufficiency × Prednisolone × 30 days × Clear all

Phase

Status

Not yet recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Burkitt Lymphoma 4 Lymphoma, Large B-Cell, Diffuse 3 Prostatic Neoplasms 2 Neoplasms 2 Lymphoma, Follicular 2 Leukemia, Biphenotypic, Acute 2 Hodgkin Disease 2 Triple Negative Breast Neoplasms 1 Recurrence 1 Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 1 Precursor Cell Lymphoblastic Leukemia-Lymphoma 1 Precursor B-Cell Lymphoblastic Leukemia-Lymphoma 1 Ovarian Neoplasms 1 Myasthenia Gravis 1 Lymphoma 1 Lugano Classification Limited Stage Hodgkin Lymphoma AJCC v8 1 Endometrial Neoplasms 1 Down Syndrome 1 Carcinoma, Non-Small-Cell Lung 1 Adrenal Insufficiency 1 Adenocarcinoma 1

Interventions

ravulizumab 1 Prednisone 1 Prednisolone 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT07221838 2026-03-03

OCTAGON

Alexion Pharmaceuticals, Inc.

Phase 4 Not yet recruiting

Adrenal Insufficiency, Myasthenia Gravis

Data powered by HemOnc (CC BY 4.0) Colophon ⚡